Сравнительная характеристика молекулярно-генетических особенностей в медуллобластомах у взрослых и детей

Список литературы

1. Коршунов А.Г., Сычева Р. В., Горелышев С. К., Озеров С. С., Голанов А. В. Аномалии хромосомы 17 в медуллобластомах и их прогностическое значение. Вопросы Нейрохирургии, 2007
2. Мацко Д.Е., Коршунов А. Г. Атлас опухолей центральной нервной системы (гистологическое строение) С-Пб.-1998−200с
3. Озеров С.С. Клиническая и гистобиологическая характеристика медуллобластом. Дисс. канд. мед. наук. М., 1999
4. Смирнов Л.И. Гистогенез, гистология и топография опухолей мозга. М. Медгиз-1951−476с
5. Смирнов Л.И. Опухоли головного и спинного мозга. М. Медгиз-1962−240с
6. Хоминский Б.С. Гистологическая диагностика опухолей центральной нервной системы. М., 1969
7. Abacioglu U., Uzel О., Sengoz M., Turkan S., and Ober A. Medulloblastoma in adults: treatment results and prognostic factors. Int. J. Radiation Oncology Biol. Phys. 54,3:855−860, 2002
8. Adesina A.M. Molecular heterogeneity in medulloblastoma with implications for differing tumor biology. J Child Neurol 14:411−417, 1999
9. Adesina A.M., Dunn S.T., Moore W.E. and Nalbantoglu J. Expression of p27kipl and p53 in medulloblastoma: relationship with cell proliferation and survival. Pathology Research and Practice 196:243−250, 2000
10. Albertson D.G. and Pinkel D. Genomic microarrays in human genetic disease and cancer. Human Molecular Genetics, 12,2:145−152, 2003
11. Albright A.L., Wisoff J.H., Zeltzer P.M., Boyett J.M., Rorke L.B., Stanley P. Effects of medulloblastoma resection on outcome in children: a report from the Children’s Cancer Group. Neurosurgery 38 (2):265−271, 1996
12. Aldosari N., Bigner S.H., Burger P.C., Becker L., Kepner J.L., Friedman H.S., McLendon R.E. MYCC and MYCN oncogene amplification in medulloblastoma. Arch Pathol Lab Med 126:540−544, 2002
13. Aldosari N., Rasheed B.K.A., McLendon R.E., Friedman H.S., Bigner D.D., Bigner S.H. Characterization of chromosome 17 abnormalities in medulloblastomas. Acta Neuropathol 99:345−351, 2000
14. Altaba A.R., Sanchez P. and Dahmane N. Gli and Hedgehog in cancer: tumours, embryos and stem cells. Nature Review/Cancer 2:361−372, 2002
15. Ang C., Hauerstock D., Guiot M.-C., Kasymjanova G., Roberge D., Kavan P. and Muanza T. Characteristics and outcomes of medulloblastoma in adults. Pediatr Blood Cancer 51: 603−607, 2008
16. Bailey P., Cushing H. Medulloblastoma cerebelli: a common type of midcerebellar glioma of childhood. Arch Neurol Psychiatry 14:192−223, 1925
17. Bar E.E., Chaudhry A., Farah M.H., and Eberhart C.G. Hedgehog signaling promotes medulloblastoma survival via Bc/II. The American Journal of Pathology 170:347−355, 2007
18. Baryawno N., Sveinbjornsson B., Kogner P., and Johnsen J.I. Medulloblastoma a disease with disorganized developmental signaling cascades. Cell Cycle 9,13:2548−2554, 2010
19. Bodey B., Bodey B. Jr., Siegel S.E. and Kaiser H.E. Fas (APO-1, CD95) receptor expression and new option for immunotherapy in childhood medulloblastomas. Anticancer Research 19:3293−3314,1999
20. Bont J.M. de, Packer R.J., Michiels E.M., Boer M.L. den, and Pieters R. Biological background of pediatric medulloblastoma and ependymoma: a review from a translational research perspective. Neuro-Oncology 10:10 401 060,2008
21. Boon K. Eberhart C.G., and Riggins GJ. Genomic amplification of Orthodenticle Homologue 2 in medulloblastomas. Cancer Res 65 (3):703−707, 2005
22. Boon K., Edwards J., Siu I-M., Olschner D., Eberhart C.G., Marra M.A., Strausberg R.L. and Riggins G. Comparison of medulloblastoma and normal neural transcriptomes identifies a restricted set of activated genes. Oncogene 22:7687−7694, 2003
23. Bouffet E. Medulloblastoma in infants: the critical issues of the dilemma. Current Oncology 17(3):2−3, 2010
24. Brandes A.A., Franceschi E., Tosoni A., Blatt V., Ermani M. Long-term results of a prospective study on the treatment of medulloblastoma in adults Cancer 110:2035−2041, 2007
25. Brandes A.A., Franceschi E., Tosoni A., Reni M., Gatta G., Vecht C., Kortmann R.D. Adult neuroectodermal tumors of posterior fossa (medulloblastoma) and of supratentorial sites (stPNET). Critical Reviews in Oncology/Hematology 71:165−179, 2009
26. Brandes A. A., Paris M.K. Review of the prognostic factors in medulloblastoma of children and adults. Critical Reviews in Oncology/ Hematology 50: 121−128, 2004
27. Briggs K.J., Eberhart C.G., and Watkins D.N. Just say no to ATOH: How HIC1 methylation might predispose medulloblastoma to lineage addiction. Cancer Res. 68, 21:8654−8656, 2008
28. Bruggers C.S., Tai K-F., Murdock T., Sivak L., Le K., Perkins S.L., Coffin C.M., and Carroll W.L. Expression of the c-Myc protein in childhood medulloblastoma. Journal of Pediatric Hematology/Oncology 20,1:18−25, 1998
29. Castellino R.C., Bortoli M. De, Lu X., Moon S-H., Nguyen T-A., Shepard M.A., Rao P.H., Donehower L.A., Kim J.Y.H. Medulloblastomas overexpess the p53-inacrivating oncogene WTP1/PPM1D. J Neurooncol, 86(3): 245−256, 2008
30. Chan A.W., Tarbell N.J., Black P. Mcl., Louis D.N., Frosch M.P., Ancukiewicz M., Chapman P., Loeffler J.S. Adult medulloblastoma: prognostic factors and patterns of relapse. Neurosurjery 47,3:625−632, 2000
31. Cleveland W. J Am Stat Assoc 74:829−836, 1979
32. Cleveland W: Am Stat 35:54, 1981
33. Cong F., Zhang J., Pao W., Zhou P and Varmus H. A protein knockdown strategy to study the function of p-catenin in tumorigenesis. BMC Molecular Biology 4:10, 2003
34. Corcoran A., Maestro R.F. Del. Testing the «Go or Grow» hypothesis in human medulloblastoma cell lines in two and three dimentions. Neurosurgery 53:174−183,2003
35. Crawford J.R., MacDonald T.J., Packer R. Medulloblastoma in childhood: new biological advances. Lancet Neurol6:1073−1085, 2007
36. Curran E. K., Le G. M., Sainani K. L., Propp J. M., Fisher P. G.
37. Do children and adults differ in survival from medulloblastoma? A study from the SEER registry. JNeurooncol, 95:81−85, 2009
38. Curran E. K., Sainani K. L., Le G. M., Propp J. M., and Fisher P. G. Gender affects survival for medulloblastoma only in older children and adults: a study from the surveillance epidemiology and end results registry. Pediatr Blood Cancer 52:60−64, 2009
39. Cvekl A. Jr., Zavadil J., Birshtein B.K., Grotzer M.A., Cvekl A. Analysis of transcripts from 17pl3.3 in medulloblastoma suggests ROX/MNT as a potential tumour suppressor gene. European Journal of Cancer 40:2525−2532, 2004
40. Dahlback H-S. S., Brandal P., Gorunova L., Widing E., Meling T.R., Krossness B.K., and Heim S. Genomic aberrations in pediatric gliomas and embryonal tumors. Genes, Chromosomes & Cancer DPI: 10.1002/gcc.20 898, 2011
41. Dahmen R.P., Koch A., Denkhaus D., Tonn J.C., Sorensen N., Berthold F., Birchmeier W., Wistler O.D., and Pietsch T. Deletion of AXIN1, a component of the WNT/wingless pathway, in sporadic medulloblastomas. Cancer Research 61:7039−7043, 2001
42. Duman-Scheel M., Weng L, Xin S. and Du W. Hedgehog regulates cell growth and proliferation by inducing Cyclin D and Cyclin E. Nature 417:299 304,2002
43. Duplan S.M., Theoret Y., and Kenigsberg R.L. Antitumor activity of fibroblast growth factors (FGFs) for medulloblastoma may correlate with FGF receptor expression and tumor variant. Clinical Cancer Research 8:246−257, 2002
44. Eberhart C.G. In search of the medulloblast: neuronal stem cells and embryonal brain tumor. Neurosurgery Clinics of North America 18:59−69, 2007
45. Eberhart C.G. Molecular diagnosis in embrional brain tumors. Brain Pathology 21:96−101,2011
46. Eberhart C.G., Burger P.C. Anaplasia and grading in medulloblastomas. Brain Pathol 13:376−385, 2003
47. Eberhart C. G, Chaudhry A., Daniel R.W., Khaki L., Shah K.V. and Gravitt P. Increased p53 immunopositivity in anaplastic medulloblastoma and supratentorial PNET is not caused by JC virus. BMC Cancer 5:19 DQI:10.1186/1471−2407−5-19, 2005
48. Eberhart C. G, Cohen K. J, Tihan T, Goldthwaite P. T, and Burger P.C. Medulloblastomas with systemic metastases: evaluation of tumor histopathology and clinical behavior in 23 patients. Journal of Pediatric Hematology/Oncology 25,3:198−203, 2003
49. Eberhart C. G, Kratz J, Schuster A, Goldthwaite P, Cohen K, Perlman E. J, and Burger P.C. Comparative genomic hybridization detects an increased number of chromosomal alterations in large cell/anaplastic medulloblastomas. Brain Pathol 12:36−44, 2002
50. Eberhart C.G., Tihan T., and Burger P.C. Nuclear localization and mutation of P-catenin in medulloblastomas. Journal of Neuropathology and Experimental Neurology 59 (4): 333−337,2000
51. Ellison D.W. Childhood medulloblastoma: novel approaches to the classification of a heterogeneous disease. Acta Neuropathol, 120(3): 305−16, 2010
52. Fari X. and Eberhart C.G. Medulloblastoma stem cells. Jornal of Clinical Oncology 26,17:2821−2827, 2008
53. Fan X., Matsui W., Khaki L., Stearns D., Chun J., Li Y-M., and Eberhart C.G. Notch pathway inhibition depletes stem-like cells and blocks engraftment in embryonal brain tumors. Cancer Research 66,15:7445−7452,2005
54. Fernandez-Teijeiro A., Betensky R., Sturla L.M., Kim J. Y. H., Tamayo P., and Pomeroy S.L. Combining gene expression profiles and clinical parameters for risk stratification in medulloblastomas. J Clin Oncol 22:994−998, 2004
55. Fisher P.G., Burger P.C. and Eberhart C.G. Biologic risk stratification of medulloblastoma: the real time is now. Journal of Clinical Oncology 22 (6):971−974,2004
56. Fruhwald M.C. and Plass C. Metastatic medulloblastoma — therapeutic success through molecular target identification? The Pharmacogenomics Journal 2:710, 2002
57. Gan D-D., Reiss K., Carrill T., Valle L. Del., Croul S., Giordano A., Fishman P. and Khalili K. Involvement of Wnt signaling pathway in murine medulloblastoma induced by human neurotropic JC virus. Oncogene 20:48 644 870,2001
58. Gessi M., Muehlen A. zur, Lauriola L., Gardiman M.P., Giangaspero F. and Pietsch T. TP53, b-catenin and c-myc/ N-myc status in embryonal tumours with ependymoblastic rosettes. Neuropathology and Applied Neurobiology 37:406−413,2011
59. Giangaspero F., Perilongo G., Fondelli M.P., Brisigotti M., Carollo C., Burnelli R., Burger P.C., and Garre M.L. Medulloblastoma with extensive nodularity: a variant with favorable prognosis. J Neurosurg 91:971−977, 1999
60. Giangaspero F., Wellek S., Masuoka J., Gessi M., Kleihues P., Ohgaki H. Stratification of medulloblastoma on the basis of histopathological grading. Acta Neuropathol 112:5−12,2006
61. Gilbertson RJ. Medulloblastoma: signaling a change in treatment. The Lancet Oncology 5:209−218, 2004
62. Gilbertson R.J. & Clifford S.C. PDGFRB is overexpressed in metastatic medulloblastoma. Nature Genetics 35,3:197−198, 2003
63. Gilbertson R.J. and Gajjar A. Molecular biology of medulloblastoma: will it ever make a difference to clinical management? Journal of Neuro-Oncology 75:273−278, 2005
64. Giordana T. M., Agostino C. D', Polio B., Silvani A., Ferracini R., Paiolo A., Ghiglione P. and Chio A. Anaplasia is rare and does not influence prognosis in adult medulloblastoma. J. Neuropathol Exp Neurol, 64, 10: 869−874, 2005
65. Giordana M.T., Cavalla P., Dutto A., Borsotti L., Chio A. and Schiffer D. Is medulloblastoma the same tumor in children and adults? Journal of Neuro-Oncology 35:169−176, 1997
66. Giordana M. T., Duo D., Gasverde S., Trevisan E., Boghi A., Morra I., Pradotto L., Mauro A. and Chio A. MDM2 overexpression is associated with short survival in adult with medullodlastoma. Neuro-Oncology 4: 115−122, 2002
67. Giordana M.T., Migheli A. and Pavanelli E. Isochromosome 17q is a constant finding in medulloblastoma. An interphase cytogenetic study on tissue sections. Neuropathology and Applied Neurobiology 24:233−238, 1998
68. Graf E., Schmoor C., Sauerbrei W. and Schumaher M. Assessment and comparison of prognostic classification schemes for survival data. Statistics in Medicine 18:2529−2545, 1999
69. Haas T.G.K.J. de, Kool M. Clinicopathological features of medulloblastoma: an overview with an emphasis on molecular biology. Clinical Neuropathology 26 (3): 93−110, 2007
70. Hambardzumyan D., Becher O.J. and Holland E.C. Cancer stem cells and survival pathways. Cell Cycle 7,10:1371−1378, 2008
71. Haslam R.H.A., Lamborn K.R., Becker L.E., and Israel M.A. Tumor cell apoptosis present at diagnosis may predict treatment outcome for patients with medulloblastoma. Journal of Pediatric Hematology/Oncology 20,6:520−527, 1998
72. Hernan R., Fasheh R., Calabrese C., Frank A.J., Maclean K.H., Allard D., Barraclough R., and Gilbertson R.J. ERBB2 up-redulates S100A4 and severalother prometastatic genes in medulloblastoma. Cancer Research 63:140−148, 2003
73. Holland H, Koschny R, Krupp W, Meixensberger J, Bauer M, Schober R, Kirsten H, Ganten T. M, Ahnert P. Cytogenetic and molecular biological characterization of an adult medulloblastoma. Cancer Genetics and Cytogenetics 178:104−113, 2007
74. Horbinski C, Miller C. R, Perry A. Gone FISHing: clinical lessons learned in brain tumor molecular diagnostics over the last decade. Brain Pathology 21:57−73, 2011
75. Howng S-L., Wu C-H, Cheng T-S, Sy W-D, Lin P-C.K, Wang C, Hong Y-R. Differential expression of Wnt genes, P-catenin and E-cadherin in human brain tumors. Cancer Letters 183:95−101, 2002
76. Huang H, Mahler-Araujo B. M, Sankila A, Chimelli L, Yonekawa Y, Kleihues P, and Ohgaki H. APC mutation in sporadic medulloblastomas. The American Journal of Pathology 156:433−437, 2000
77. Hubbard J. L, Scheithauer B. W, Kispert D. B, Carpenter S. M, Wick M. R, and Laws E.R. Jr. Adult cerebellar medulloblastomas: the pathological, radiographic, and clinical disease spectrum. J Neurosurg 70:536 544, 1989
78. Inazawa J., Inoue J. and Imoto I. Comparative genomic hybridization (CGH)-arrays pave the way for identification of novel cancer-related genes. Cancer Sci 95 (7):559−563, 2004
79. Kagawa N., Maruno M., Suzuki T., Hashiba T., Hashimoto' N., Tzumoto S., Yoshimine T. Detection of genetic and chromosomal aberrations in medulloblastomas and primitive neuroectodermal tumors with DNA microarrays. Brain Tumor Pathol 23:41−47, 2006
80. Katsetos C., Valle L. Del, Legido A., Chadarevian J-P. de, Perentes E., Mork S.J. On the neuronal/neuroblastic nature of medulloblastomas: a tribute to Pio del Rio Hortega and Moises Polak. Acta NeuropathoL105: l-13,2003
81. Kasuga C., Nakahara Y., Ueda S., Hwakins C., Taylor M.D., Smith' C.A., and Rutka J.T. Expression of MAGE and GAGE genes in medulloblastoma and modulation of resistance to chemotherapy. J Neurosurg Pediatrics 1:305−313,2008
82. Katoh M. WNT/PCP signaling-pathway and human cancer (review). Oncology Reports 14:1583−1588, 2005
83. Kaur J. and Sanial S.N. Association of PI3-kinase and Wnt signaling in non-steroidal anti-inflammatory drug-induced apoptosis in experimental colon cancer. American Journal of Biomedical Sciences l (4):395−405, 2009
84. Kenney A.M., Cole M.D. and Rowitch D.H. Nmyc upregulation by Sonic Hedgehog Signaling promotes proliferation in developing cerebellar granule neuron precusors. Development 130:15−28, 2003
85. Khalil E.B. Treatment results of adults and children with medulloblastoma NCI, Cairo University experience. Journal of the Egyptian Nat. Cancer Inst. 20(2): 175−186, 2008
86. Kim J.Y.H., Koralnik I.J., LeFave M., Segal R.A., Pfister L-A. and Pomeroy S.L. Medulloblastomas and primitive neuroectodermal tumors rarely contain polyomavirus DNA sequences. Neuro-Oncology 4/3(165−170):1522−8517,2002
87. Koch A., Hrychyk A., Hartmann W., Waha A., Mikeska T., Waha A., Schuller U., Sorensent N., Berthold F., Goodyer C.C., Wiestler O.D. Birchmeier W., Behrens J. and Pietsch T. Mutations of the Wnt antagonist
88. AXIN2 (Conductin) result in TCF-dependent transcription in medulloblastomas. Int. J. Cancer 121:284−291, 2007
89. Koch A., Tonnt J., Kraus J.A., Sorensent N., Albrecht S., Wiestier O.D. and Pietsch T. Molecular analysis of the lissencephaly gene 1 (LIS-1) in medulloblastomas. Neuropathology and Applied Neurobiology 22:233−242, 1996
90. Korn E.L. Censoring distributions as a measure of follow-up in survival analysis. Statistics in Medicine 5:255−260, 1986
91. Korshunov A., Benner A., Remke M., Lichter P., Deimling A. von, Pfister S. Accumulation of genomic aberrations during clinical progression of medulloblastoma. Acta Neuropathol, 116 (4): 383−390, 2008
92. Kortmann R-D., Kuhl J., Timmermann B., Mittler U., Urban C., Budach V., Richter E., Willich N., Flentje M., Berthold F., Slave I., Wollf J.,
93. Lai R. Survival of patients with adult medulloblastoma. A population-based study. Cancer, 112, 7:1568−1574, 2008
94. Lamont J.M., Mcmanamy C.S., Pearson A.D., Clifford S.C., and Ellison D.W. Combined histopathological and molecular cytogenetic stratification of medulloblastoma patients. Clinical Cancer Research 10:54 825 493, 2004
95. Lee Y. and McKinnon PJ. DNA ligase IV suppresses medulloblastoma formation. Cancer Research 62:6395−6399, 2002
96. Lee Y., Miller H.L., Jensen P., Hernan R., Connelly M., Wetmore C., Zindy F., Roussel M.F., Curran T., Gilbertson R.C., and McKinnon P.J. A molecular fingerprint for medulloblastoma. Cancer Research 63:5428−5437, 2003
97. Leonard J.R., Cai D.X., Rivet D.J., Kaufinan B.A., Park T.C., Levi B.K., Perry A. Large cell/anaplastic medulloblastomas and medullomyoblastomas- clinicopathological and genetic features. JNeurosurg 95:82−88, 2001
98. Lescop S., Lellouch-Tubiana A., Vassal G. and Basnard-Guerin C. Molecular genetic studies of chromosome 11 and chromosome 22q DNA sequences in pediatric medulloblastomas. Journal of Neuro-Oncology 44:119 127, 1999
99. Li X-N., Shu Q., Su J.M., Adesina A.M., Wong K.K., Perlaky L., Antalffyt B.A., Blaney S.M. and Lau C.C. Differential expression of survivin splice isoforms in medulloblastomas. Neuropathology and Applied Neurobiology 33:67−76, 2007
100. Lindsey J.C., Anderton J.A., Lusher M. E, and Clifford S.C. Epigenetic events in medulloblastoma development. Neurosurg Focus 19, 5:1−13, 2005
101. Liu J., Li J-W., Gang Y., Guo L., Li H. Expression of leukemia-inhibitory factor as an autocrinal growth factor in human meduloblastomas. J Cancer Res Clin Oncol 125:475−480
102. Lo K.C., Ma C., Bundy B.N., Pomeroy S.L., Eberhart C.G., and Cowell J.K. Gain of lq is a potential univariate negative prognostic marker for to survival in medulloblastoma. Clin Cancer Res 13 (23):7022−7028, 2007
103. Lo K.C., Rossi M.R., Eberhart C.G., Cowell J.K. Genome wide copy number abnormalities in pediatric medulloblastomas as assessed by array comparative genome hybridization. Brain Pathol, 17(3):282−96,2007
104. Malheiros S. M. F., Franco C. M. R., Stavale J. N., Santos A. J., Borges L. R. R., Pelaez M. P., Ferraz F. A. P. and Gabbai A. A. Medulloblastoma in adult: a series from Brazil. Journal of Neuro-Oncology 60: 247−253, 2002
105. Marcotullio L. Di, Ferretti E, Smaele E. De, Argenti B, Mincione C, Zazzeroni F, Gallo R, Masuelli L, Napolitano M, Maroder M, Modesti A, 1. I/pTp"1 1
106. Giangaspero F, Screpanti I, Alesse E, and Guilino A. REN is a suppressor of Hedgehog signaling and is deleted in human medulloblastoma. PNAS 101,29:10 833−10 838, 2004
107. McLendon R. E, Friedman H. S, Kun L.E. & Bigner S.H. Diagnostic markers in pediatric medulloblastoma: a Pediatric Oncology Group Study. Histopathology 34:154−162, 1999
108. Min H.S., Lee Y.J., Park K., Cho B-K., Park S-H. Medulloblastoma: histopathologic and molecular markers of anaplasia and biologic behavior. Acta Neuropathol 112:13−20, 2006
109. Miralbell R., Tolnay M., Bieri S., Probst A., Sappino A-P., Berchtold W., Pepper M.S. and Pizzolato G. Pediatric medulloblastoma: prognostic value of p53, bcl-2, Mib-1, and microvessel density. Journal of Neuro-Oncology 45: 103−110, 1999
110. Monje M., Beachy P.A., and Fisher P.G. Hedgehog, Flies, Wnts and MYCs: the time has come for many things in medulloblastoma. Journal of Clinical Oncology 29(11):1395−1398, 2011
111. Nicholson J., Wickramasinghe C., Ross F., Crolla J., Ellison D. Imbalances of chromosome 17 in medulloblastomas determined by comparative genomic hybridization and fluorescence in situ hybridization. J Clin Pathol: Mol Pathol 53:313−319, 2000
112. Northcott P.A., Hielscher T., Dubuc A., Mack S., Shih D., Remke M., Al-Halabi H., Albrecht S., Jabado N., Eberhart C.G., Grajkowska W., Weiss W.A., Clifford S.C., Bouffet E., Rutka J.T., Korshunov A., Pfister S.,
113. Taylor M.D. Pediatric and adult sonic hedgehod medulloblastomas are clinically and moleculary distinct. Acta Neuropathol, DPI: 10.1007/s00401−011−0846−7, 2011
114. Pnguru P., Karslioglu Y., Pzcan A. and Celik E. Anti-apoptotic and growth-promoting markers in adult medulloblastomas. Clinical Neuropathology 29(6):384−389, 2010
115. Padovani L., Andre N., Carrie C., Muracciole X. Childhood and adult medulloblastoma- What difference? Cancer/Radiotherapie 13:530−535, 2009
116. Park P.C., Taylor M.D., Mainprize T.G., Becker L.E., Ho M., Dura W.T., Squire J., and Rutka J.T. Transcriptional profiling of medulloblastoma in children. J Neurosurg 99:534−541, 2003
117. Pelc K., Vincent S., Ruchoux M-M., Kiss R., Pochet R., Sariban E., Decaestecker C., Heizmann C.W. Calbindin-D28k a marker of reccurence for medulloblastoma. Cancer 95, 2:410−419, 2002
118. Peringa J., Fung K-M., Muragaki Y. and Trojanowski J.O. The cellular and molecular biology of medulloblastoma. Current Opinion in Neurology 8:437−440,1995
119. Pfister S., Hartmann C., and Korshunov A. Histology and molecular pathology of pediatric brain tumors. J Child Neurol, 24(11): 1375−86, 2009
120. Pfister S.M., Korshunov A., Kool M., Hasselblatt M., Eberhart C., Taylor M. Molecular diagnosis of CNS embryonal tumors. Acta Neuropathol, 120(5):553−66, 2010
121. Piccirillo S.G.M., Binda E., Fiocco R., Vescovi A.L., Shah K. Brain cancer stem cells. J Mol Med 87:1087−1095, 2009
122. Pizer B., Clifford S. Medulloblastoma: new insights into biology and treatment. Arch Dis Child Educ Pract Ed 93:137−144, 2008
123. Pizer B.L., Clifford S. C. The potential impact of tumour biology on improved clinical practice for medulloblastoma: progress towards biologically driven clinical trials. British Journal of Neurosurgery 23 (4): 364−375, 2009
124. Poelen J., Bernsen H.J.J.A. and Prick M.J.J. Metastatic medulloblastoma in an adult- treatment with temozolomide. Case report. Acta Neurol. Belg. 107:51−54, 2007
125. Polkinghorn W., Tarbell N. Medulloblastoma: tumorigenesis, current clinical paradigm, and efforts to improve risk stratification. Nat Clin Pract Gncol. 4:295−304, 2007
126. Pomeroy S.L., Cho Y-J. Molecular fingerprints of medulloblastoma and their application to clinical practice. Future Pncol. 7 (3):327−329, 2011
127. Przkora R., Meyer-Puttlitz B., Schmitt O., Berthold F., Nothen M., Krauss J., Tonn J.C., Deimling A. von, Wiestler O.D., Pietsch T. Analysis of the TSC2 gene in human medulloblastoma. Acta Neuropathol 102:380−384, 2001
128. Pui C-H., Gajjar A., Kane J.R., Qaddoumi I.A. and Pappo A.S. Challenging issues in pediatric oncology. Nature Reviews Clinical Oncology- DPI: 10.1038/nrclinonc.2011.95
129. Ramachandran C., Khatib Z., Escalon E., Fonseca H.B., Jhabvala P., Medina L.S., Souza B. D', Ragheb J., Morrison G., Melnick S J. Molecular studies in pediatric medulloblastomas. Brain Tumor Pathol 19:15−22, 2002
130. Ray A., Ho M., Ma J., Parkers R.K., Mainprize T.G., Ueda S., McLaughlin J., Bouffet E., Rutka J.T., and Hawkins C.E. A clinicobiological model predicting survival in medulloblastoma. Clinical Cancer Research 10:7613−7620, 2004
131. Reddy A.T. and Packer RJ. Medulloblastoma. Current opinion in Neurology 12:681−685, 1999
132. Rickert C. H, Paulus W. Comparative genomic hybridization in Central and Peripheral Nervous System tumors of childhood and adolescence. Journal of Neuropathology and Experimental Neurology 63 (5):399−417, 2004
133. Riffaud L, Saikali S, Leray E, Hamlat A, Haegelen C, Vauleon E, and Lesimple T. Survival and prognostic factors in a series of adult with medulloblastomas. J Neurosurg 111:478−487, 2009
134. Rochkind S, Blatt I, Saden M, Goldhammer Y. Extracranial metastases of medulloblastoma in adults: literature review. Journal of Neurology, Neurosurgery, and Psychiatry 54:80−86, 1991
135. Rodriguez F. J, Eberhart C, O’Neill B. P, Slezak J, Burger P.C., Goldthwaite P, Wu W, Giannini C. Histopathologic grading of adult medulloblastomas. Cancer 109(12):2557−2565, 2007
136. Rodriguez F. J, Scheithauer B.W. Anaplastic medulloblastoma with granular cell change. Acta Neuropathol, 113(1): 95−99, DPI: 10.1007/S00401−006−0121−5. 2006
137. Rossi A, Caracciolo V, Russo G, Reiss K, and Giordano A. Medulloblastoma: from molecular pathology to therapy. Clin Cancer Res 14(4):971−976, 2008
138. Rossi M.R., Conroy J., McQuaid D., Nowak N.J., Rutka J.T., and Cowell J.K. Array CGH analysis of pediatric medulloblastomas. Genes, Chromosomes & Cancer 45:290−303,2006
139. Roussel M.F. New concepts in organ site research on medulloblastoma: genetics and genomics. Future Oncol. 6(8):1229−1231, 2010
140. Rubin J.B. and Rowitch D.H. Medulloblastoma: a problem of developmental biology. Cancer Cell 7−8,2002
141. Rudin C.M., Hann C.L., Laterra J., Yauch R.L., Callahan C.A., Fu L., Holcomb T., Stinson J., Gould S.E., Coleman B., LoRuss P.M., Hoff D.D. Von, Sauvage F.J. de, and A. Low J.A. Treatment of medulloblastoma with
142. Hedgehog Pathway Inhibitor GDC-0449. The New England Journal of
143. Medicine 361:1173−1178, 2009
144. Russo C., Pellarin M., Tingby O., Bollen A.W., Lamborn K.R., Mohapatra G., Collins V.P., Feuerstein B.G. Comparative genomic hybridization in patients with supratentorial and infratentorial primitive neuroectodermal tumors. Cancer 86:331−339, 1999
145. Rutkowski S., Hoff K. von, Emser A., Zwiener I., Pietsch T., Figarella-Branger D., Giangaspero F., Ellison D.W. Garre M-L., Biassoni V.,
146. Grundy R.G., Finlay J.L., Dhall G., Raquin M-A., and Grill J. Survival and prognostic factors of early chilshood medulloblastoma: an international meta-analysis. J Clin Oncol 28 DPI: 10.1200/JCQ.2010.30.2299, 2010
147. Sarkar C., Deb P., Sharma M.C. Medulloblastomas: new direction in risk stratification. Neurology India 54:16−23, 2006
148. Schubert T.E.P., and Cervos-Navarro J. The histopathologycal and clinical relevance of apoptotic cell death in medulloblastomas. Journal of Neuropathology and Experimental Neurology 57(1):10−15, 1998
149. Scott D.K., Straughton D., Cole M., Bailey S., Ellison D.W., Clifford S.C. Identification and analysis of tumor suppressor loci at chromosome 10q23.3−10q25.3 in medulloblastoma. Cell Cycle 5 (20):2381−2389, 2006
150. Segal R.A., Goumnerova L.C., Kwon Y.K., Stiles C.D., and Pomeroy S.L. Expression of the neurotrophin receptor TrkC is linked to a favorable outcome in medulloblastoma. Medical Sciences 91:12 867−12 871, 1994
151. Shimato S., Natsume A., Takeuchi H., Fujii M., Ito M., Ito S., Park I.H., Bang J.H., Kim S.U. and Yoshida J. Human neural stem cells target and deliver therapeutic gene to experimental leptomeningeal medulloblastoma. Gene Therapy 14(15):1132−42, 2007
152. Siu I-M., Lai A., Blankenship J.R., Aldosari N., and Riggins G.J. C-MYC promoter activation in medulloblastoma. Cancer Research 63:47 734 776, 2003
153. Smaele E. De., Marcotullio L. Di., Ferretti E., Screpanti I., Alesse E., Guilino A. Chromosome 17p deletion in human medulloblastoma. A missing checkpoint in the Hedgehog pathway. Cell Cycle 3, 10:111−114, 2004
154. Sommer A., Waha A., Tonn J., Sorensen N., Hurlin P.J., Eisenman R.N., Luscher B. and Pietsch T. Analysis of the max-binbing protein MNT in human medulloblastomas. Int. J. Cancer 82:810−816, 1999
155. Stearns D., Chaudhry A., Abel T.W., Burger P.C., Dang C.V., and Eberhart C.G. C-MYC overexpression causes anaplasia in medulloblastoma. Cancer Res 66, 2:673−681, 2006
156. Sure U., Bertalanffy H., Isenmann St., Brandner S., Berghorn W.J., Seeger W., and Aguzzi A. Secondary manifestation of medulloblastoma: metastases and local reccurences in 66 patients. Acta Neurochirurgica 136:117 126, 1995
157. Tabori U., Baskin B., Shago M., Alon N., Taylor M.D., Ray P.N., Bouffet E., Malkin D., and Hawkins C. Universal poor survival in children with medulloblastoma hardoring somatic TP53 mutations. J Clin Oncol 28, DPI: 10.1200/JCQ.2009.23.5952, 2010
158. Taylor M.D., Mainprize T.G., Rutka J.T. Molecular insight into medulloblastoma and central nervous system primitive neuroectodermal tumor biology from hereditary syndromes: a review. Neurosurgery 47(4):888−901, 2000
159. Tibiletti M.G. Interphase FISH as a new tool in tumor pathology. Cytogenetic and Genome Research 118:229−236, 2007
160. Tibshirani R., Hastie T., Narasimhan B., and Chu G. Diagnosis of multiple cancer types by shrunken centroids of gene expression PNAS 99(10): 6567- 6572, 2002
161. Toftgard R. Hedgehod signaling in cancer. CMLS Cellular and Molecular Life Sciences 57:1720−1731, 2000
162. Tong W-M., Ohgaki H., Huang H., Granier C., Kleihues P., and Wang Z-Q. Null mutation of DNA strand break-binding molecule poly (ADP-ribose) polymerase causes medulloblastomas in p53 mice. American Journal of Pathology 162, 1:343−352, 2003
163. Uziel T., Zindy F., Sherr C.J., Roussel M.F. The CDK ingibitor pl8Ink4c is a tumor suppessor in medulloblastoma. Cell Cycle 5 (4):363−365, 2006
164. Wu X, Northcott P. A, Croul S. and Taylor M.D. Mouse models of medulloblastoma. Chinese Journal of Cancer 30(7):442−448, 2011
165. Yasue M, Tomita T, Engelhard H, Gonsales-Crussi F, McLone D. G, and Bauer K.D. Prognostic importance of DNA ploidy in medulloblastoma of childhood. J. Neurosurg 70:385−391, 1989
166. Yin X-L, Pang J C-S. and Ng H-K. Identification of a region of homozygous deletion on 8p22−23.1 in medulloblastoma. Oncogene 21:14 611 468, 2002
167. Zurawel R. H, Allen C, Chiappa S, Cato W, Biegel J, Cogen P, Sauvage F. de, and Raffel C. Analysis of PTCH/SMO/SHH pathway genes in medulloblastoma. Genes, Chromosomes & Cancer 27:44−51, 2000